{"id":"levocetirizine-only","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Somnolence"},{"rate":"5-8","effect":"Headache"},{"rate":"3-5","effect":"Fatigue"},{"rate":"2-4","effect":"Dry mouth"},{"rate":"2-3","effect":"Pharyngitis"}]},"_chembl":{"chemblId":"CHEMBL1201191","moleculeType":"Small molecule","molecularWeight":"388.90"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Levocetirizine is the active R-enantiomer of cetirizine, a second-generation antihistamine that selectively antagonizes peripheral H1 receptors. By blocking histamine binding to H1 receptors on mast cells, basophils, and endothelial cells, it prevents the release and effects of histamine, thereby reducing itching, urticaria, rhinitis, and other allergic manifestations. It has minimal central nervous system penetration due to its hydrophilic nature and low blood-brain barrier crossing.","oneSentence":"Levocetirizine is a selective H1-receptor antagonist that blocks histamine signaling to reduce allergic symptoms.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:33:54.446Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis (seasonal and perennial)"},{"name":"Chronic urticaria"},{"name":"Allergic conjunctivitis"}]},"trialDetails":[{"nctId":"NCT07341776","phase":"PHASE4","title":"Steroid Use in Treatment of Allergic Reactions to Food","status":"RECRUITING","sponsor":"Johannes Trueck","startDate":"2026-01-26","conditions":"Anaphylactic Reaction, Anaphylaxis, Allergy in Children","enrollment":160},{"nctId":"NCT07323888","phase":"NA","title":"Traditional vs. Posterior Nasal Radiofrequency Ablation for Chronic Rhinitis","status":"NOT_YET_RECRUITING","sponsor":"Chien Yu Huang","startDate":"2026-01","conditions":"Nasal Obstruction, Chronic Rhinitis, Nonallergic Rhinitis","enrollment":60},{"nctId":"NCT05565729","phase":"PHASE1","title":"A Phase I Study of LY3471851 in Healthy Participants","status":"COMPLETED","sponsor":"Nektar Therapeutics","startDate":"2022-10-05","conditions":"Healthy","enrollment":41},{"nctId":"NCT05348148","phase":"NA","title":"Comparison of the Effects for Lightening the Shiners Among Different Treatments for Rhinitis","status":"RECRUITING","sponsor":"Camillians Saint Mary's Hospital Luodong","startDate":"2020-06-16","conditions":"Allergic Rhinitis, Vasomotor Rhinitis","enrollment":450},{"nctId":"NCT03789422","phase":"PHASE4","title":"Tranexamic Acid and Spontaneous Chronic Urticaria","status":"UNKNOWN","sponsor":"University Hospital, Grenoble","startDate":"2019-12-10","conditions":"Chronic Spontaneous Urticaria","enrollment":80},{"nctId":"NCT03555890","phase":"PHASE1","title":"Bioequivalence Study Between Levocetirizine Oral Disintegrating Tablet (ODT) and Levocetirizine Immediate Release Tablet (IRT)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2018-05-18","conditions":"Rhinitis","enrollment":72},{"nctId":"NCT04399525","phase":"NA","title":"Influence of H1-antihistamines on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin.","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2019-10-28","conditions":"Pruritus","enrollment":12},{"nctId":"NCT03673384","phase":"NA","title":"Effect of Health Promotion on Allergic Rhinitis by Infrared-C Ray Irradiation","status":"COMPLETED","sponsor":"Nanhua University","startDate":"2015-03-02","conditions":"Allergic Rhinitis","enrollment":50},{"nctId":"NCT00291642","phase":"PHASE2","title":"A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2006-01-01","conditions":"Rhinitis, Allergic, Seasonal","enrollment":551},{"nctId":"NCT03371849","phase":"PHASE1","title":"PK and Safety Study of HCP1102, HGP0813 and HGP1408","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2017-07-19","conditions":"Healthy","enrollment":24},{"nctId":"NCT02447393","phase":"PHASE1","title":"Phase 1 Study of Levocetirizine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-03-18","conditions":"Dermatitis","enrollment":20},{"nctId":"NCT00866788","phase":"PHASE2","title":"A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1)","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2009-03","conditions":"Chronic Idiopathic Urticaria","enrollment":90},{"nctId":"NCT01622283","phase":"PHASE1","title":"Pharmacokinetic Study of Levocetirizine Oral Solution","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-05-02","conditions":"Rhinitis, Allergic, Perennial and Seasonal","enrollment":20},{"nctId":"NCT01008592","phase":"","title":"The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism","status":"TERMINATED","sponsor":"Wake Forest University","startDate":"2009-04","conditions":"Rhinitis, Urticaria","enrollment":11},{"nctId":"NCT00150761","phase":"PHASE4","title":"Facial Thermography Study of Levocetirizine Versus Cetirizine","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-07","conditions":"Anti-allergic Agents","enrollment":60},{"nctId":"NCT00521170","phase":"PHASE1","title":"Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-11","conditions":"Allergy","enrollment":""},{"nctId":"NCT01496911","phase":"PHASE4","title":"Effects of Levocetirizine and Hydroxyzine on Cognitive and Psychomotor Functioning During Simulated Diving","status":"COMPLETED","sponsor":"Utrecht Institute for Pharmaceutical Sciences","startDate":"2012-04","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT01651481","phase":"PHASE1","title":"Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2012-07","conditions":"Rhinitis","enrollment":28},{"nctId":"NCT01250652","phase":"PHASE4","title":"Levocetirizine Plus Bed-Time Hydroxyzine in the Management of Corticodependent Chronic Urticaria Versus Levocetirizine Alone in High Doses","status":"COMPLETED","sponsor":"Association Asthma, Bulgaria","startDate":"2011-03","conditions":"Chronic Urticaria","enrollment":24},{"nctId":"NCT01491503","phase":"PHASE1","title":"A Drug Interaction Study of Montelukast and Levocetirizine","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2011-11","conditions":"Healthy","enrollment":30},{"nctId":"NCT01567501","phase":"PHASE1","title":"Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition","status":"COMPLETED","sponsor":"IPCA Laboratories Ltd.","startDate":"2012-02","conditions":"Fed","enrollment":28},{"nctId":"NCT01557439","phase":"PHASE1","title":"Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fasting Condition","status":"COMPLETED","sponsor":"IPCA Laboratories Ltd.","startDate":"2012-02","conditions":"Fasting State","enrollment":28},{"nctId":"NCT01430260","phase":"PHASE4","title":"Omnaris Versus Levocetirizine Phase 4 Study","status":"COMPLETED","sponsor":"Handok Inc.","startDate":"2011-01","conditions":"Allergic Rhinitis","enrollment":349},{"nctId":"NCT01506063","phase":"PHASE1","title":"Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fed Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2008-01","conditions":"Healthy","enrollment":31},{"nctId":"NCT01506076","phase":"PHASE1","title":"Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fasting Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2007-12","conditions":"Fasting","enrollment":29}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":85,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Levocetirizine only","genericName":"Levocetirizine only","companyName":"University Hospital, Grenoble","companyId":"university-hospital-grenoble","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Levocetirizine is a selective H1-receptor antagonist that blocks histamine-mediated allergic responses. Used for Allergic rhinitis, Chronic urticaria, Allergic conjunctivitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}